Skip to content

Study · Measured the body's own peptide · 1996

3 results

Elevated levels of plasma vasoactive intestinal peptide in human acute myocardial infarction.

Gyöngyösi M, Németh J, Várkonyi T

International journal of cardiology1 Oct 1996Cited by 4 (Europe PMC)

PMID8894787 (opens in a new tab)DOI10.1016/0167-5273(96)02737-4 (opens in a new tab)PepBankPUB-08894787
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Natural levels measured3

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In patients with acute myocardial infarction, plasma VIP showed no further increase two or more hours after onset.

    In plain wordsIn people with a heart attack, the body's own VIP level in blood did not rise further two or more hours after onset.

    Peptide
    Vasoactive intestinal peptide (VIP, aviptadil)
    Outcome
    No significant changePlasma VIP two or more hours after onset
    Study

    n = 26

    Outcome group
    Endogenous peptide levels · Cardiovascular

    Source sentences

    Summary
    Two or more hours after the onset of acute myocardial infarction there was no subsequent increase in peripheral plasma vasoactive intestinal peptide levels (n = 26).
    1 context sentence
    Summary · context
    The plasma levels of vasoactive intestinal peptide in peripheral vein were measured in human acute myocardial infarction.

    This result measures the body's own Vasoactive intestinal peptide (VIP, aviptadil). Nobody was given the peptide. It is not evidence about taking it.

  2. 02HumanEndogenous levelObservational studyOther

    In patients with acute myocardial infarction, plasma VIP was higher within 1 h of symptom onset than normal values.

    In plain wordsIn people with a heart attack, the body's own VIP level in blood was higher than normal in the first hour.

    Peptide
    Vasoactive intestinal peptide (VIP, aviptadil)
    Outcome
    IncreasePlasma VIP within 1 h of symptom onset
    Study

    n = 9

    Comparator
    Normal values
    Outcome group
    Endogenous peptide levels · Cardiovascular

    Measurements

    Plasma VIP
    6.3 pg/ml
    Group 1, within 1 h of onset
    Plasma VIP
    2.8 pg/ml
    normal values

    Source sentences

    Summary
    The plasma vasoactive intestinal peptide level was increased within 1 h after the onset of the symptoms of acute myocardial infarction (Group 1, n = 9), compared with normal values (6.3 +/- 0.7 vs. 2.8 +/- 0.9 pg/ml, P < 0.05).
    1 context sentence
    Summary · context
    The plasma levels of vasoactive intestinal peptide in peripheral vein were measured in human acute myocardial infarction.

    This result measures the body's own Vasoactive intestinal peptide (VIP, aviptadil). Nobody was given the peptide. It is not evidence about taking it.

  3. 03HumanEndogenous levelObservational studyOther

    In patients with acute myocardial infarction, the raised plasma VIP of Group 1 had returned to normal ten days after onset.

    In plain wordsIn people with a heart attack, the early rise in the body's own VIP in blood had gone back to normal after ten days.

    Peptide
    Vasoactive intestinal peptide (VIP, aviptadil)
    Outcome
    DecreasePlasma VIP ten days after onset
    Study

    n = 9

    Outcome group
    Endogenous peptide levels · Cardiovascular

    Measurements

    Plasma VIP
    3.5 pg/ml
    Group 1, ten days after onset

    Source sentences

    Summary
    Ten days after the onset of acute myocardial infarction, the elevated plasma vasoactive intestinal peptide levels in Group 1 had normalized (3.5 +/- 0.5 pg/ml).
    1 context sentence
    Summary · context
    The plasma levels of vasoactive intestinal peptide in peripheral vein were measured in human acute myocardial infarction.

    This result measures the body's own Vasoactive intestinal peptide (VIP, aviptadil). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.